Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Elsworth

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Psychopharmacology|January 1, 1980
The effect of deprenyl, a selective monoamine oxidase B inhibitor, on sleep and mood in manC Thornton, C J Doré, J D Elsworth, et al.
Journal of Neural Transmission|January 1, 1982
The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian propertiesJ D Elsworth, M Sandler, A J Lees, et al.
Experimental Neurology|February 28, 2012
Susceptibility to a parkinsonian toxin varies during primate developmentB A Morrow, R H Roth, D E Redmond, et al.
Brain Research|September 10, 1990
3-Acetylpyridine results in degeneration of the extrapyramidal and cerebellar motor systems: loss of the dorsolateral striatal dopamine innervationA Y Deutch, J D Elsworth, R H Roth, et al.
Journal of Neural Transmission|January 1, 1986
Purification and characterization of tribulin, and endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor bindingJ D Elsworth, D Dewar, V Glover, et al.
Neuroscience|October 8, 1997
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)J R Taylor, J D Elsworth, R H Roth, et al.
Pharmacology, Biochemistry, and Behavior|May 31, 2011
Aged monkeys as a partial model for Parkinson's diseaseP J Hurley, J D Elsworth, M C Whittaker, et al.
Brain : a Journal of Neurology|June 1, 1990
Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeysJ R Taylor, J D Elsworth, R H Roth, et al.
Life Sciences|January 11, 1991
The D1 receptor antagonist, SCH 23390, induces signs of parkinsonism in African green monkeysM S Lawrence, D E Redmond, J D Elsworth, et al.
Brain Research|April 16, 1990
MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeysJ D Elsworth, A Y Deutch, D E Redmond, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Psychopharmacology|January 1, 1980
The effect of deprenyl, a selective monoamine oxidase B inhibitor, on sleep and mood in manC Thornton, C J Doré, J D Elsworth, et al.
Journal of Neural Transmission|January 1, 1982
The contribution of amphetamine metabolites of (-)-deprenyl to its antiparkinsonian propertiesJ D Elsworth, M Sandler, A J Lees, et al.
Experimental Neurology|February 28, 2012
Susceptibility to a parkinsonian toxin varies during primate developmentB A Morrow, R H Roth, D E Redmond, et al.
Brain Research|September 10, 1990
3-Acetylpyridine results in degeneration of the extrapyramidal and cerebellar motor systems: loss of the dorsolateral striatal dopamine innervationA Y Deutch, J D Elsworth, R H Roth, et al.
Journal of Neural Transmission|January 1, 1986
Purification and characterization of tribulin, and endogenous inhibitor of monoamine oxidase and of benzodiazepine receptor bindingJ D Elsworth, D Dewar, V Glover, et al.
Neuroscience|October 8, 1997
Severe long-term 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the vervet monkey (Cercopithecus aethiops sabaeus)J R Taylor, J D Elsworth, R H Roth, et al.
Pharmacology, Biochemistry, and Behavior|May 31, 2011
Aged monkeys as a partial model for Parkinson's diseaseP J Hurley, J D Elsworth, M C Whittaker, et al.
Brain : a Journal of Neurology|June 1, 1990
Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeysJ R Taylor, J D Elsworth, R H Roth, et al.
Life Sciences|January 11, 1991
The D1 receptor antagonist, SCH 23390, induces signs of parkinsonism in African green monkeysM S Lawrence, D E Redmond, J D Elsworth, et al.
Brain Research|April 16, 1990
MPTP-induced parkinsonism: relative changes in dopamine concentration in subregions of substantia nigra, ventral tegmental area and retrorubral field of symptomatic and asymptomatic vervet monkeysJ D Elsworth, A Y Deutch, D E Redmond, et al.
Pageof 10